Imunon, Inc. (IMNN)
1.77
+0.17
(+10.62%)
USD |
NASDAQ |
Sep 02, 10:42
Imunon Cash from Operations (TTM) : -15.11M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.11M |
| March 31, 2026 | -15.03M |
| December 31, 2025 | -13.90M |
| September 30, 2025 | -14.66M |
| June 30, 2025 | -14.27M |
| March 31, 2025 | -15.83M |
| December 31, 2024 | -18.86M |
| September 30, 2024 | -18.21M |
| June 30, 2024 | -18.62M |
| March 31, 2024 | -20.81M |
| December 31, 2023 | -19.02M |
| September 30, 2023 | -20.31M |
| June 30, 2023 | -20.52M |
| March 31, 2023 | -19.24M |
| December 31, 2022 | -23.13M |
| September 30, 2022 | -23.16M |
| June 30, 2022 | -22.26M |
| March 31, 2022 | -19.46M |
| December 31, 2021 | -16.22M |
| September 30, 2021 | -14.87M |
| June 30, 2021 | -15.04M |
| March 31, 2021 | -15.38M |
| December 31, 2020 | -15.62M |
| September 30, 2020 | -17.50M |
| June 30, 2020 | -18.02M |
| Date | Value |
|---|---|
| March 31, 2020 | -19.70M |
| December 31, 2019 | -20.26M |
| September 30, 2019 | -8.606M |
| June 30, 2019 | -8.392M |
| March 31, 2019 | -7.922M |
| December 31, 2018 | -7.042M |
| September 30, 2018 | -17.29M |
| June 30, 2018 | -18.13M |
| March 31, 2018 | -18.17M |
| December 31, 2017 | -16.64M |
| September 30, 2017 | -17.10M |
| June 30, 2017 | -16.71M |
| March 31, 2017 | -16.77M |
| December 31, 2016 | -18.38M |
| September 30, 2016 | -17.62M |
| June 30, 2016 | -18.21M |
| March 31, 2016 | -19.64M |
| December 31, 2015 | -20.83M |
| September 30, 2015 | -23.44M |
| June 30, 2015 | -23.96M |
| March 31, 2015 | -22.45M |
| December 31, 2014 | -21.35M |
| September 30, 2014 | -17.96M |
| June 30, 2014 | -14.89M |
| March 31, 2014 | -16.11M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Phio Pharmaceuticals Corp. | -12.20M |
| Agenus, Inc. | -98.50M |
| Amgen, Inc. | 12.48B |
| Anika Therapeutics, Inc. | 5.977M |
| BioCryst Pharmaceuticals, Inc. | 358.99M |